Effect of lercanidipine on myocardial remodeling induced by myocardial infarction in rats

罗永鑫,姚明辉,鲁映青,贡沁燕
DOI: https://doi.org/10.3969/j.issn.1007-7669.2003.12.001
2003-01-01
Abstract:AIM: To observe the effect of lercanidipine on myocardial remodeling induced by myocardial infarction (MI). METHODS: MI was induced by permanent ligation of the left anterior descending coronary artery (LAD) in male Wistar rats. Rats were randomly divided into four groups: sham operation group, MI model group, captopril 50 mg*kg-1 group and lercanidipine 2.5 mg*kg-1 group. Three hours after the operation, the drugs or normal saline were administrated ig qd for 35 d. Twenty four hours after the last administration, rats were sacrificed and hearts were harvested. The ratio of total heart weight to body weight (THW/BW), infarct size (IS), septal thickness (ST) and left ventricular diameter (LVD) were measured. Myocardial interstitial collagen volume fraction (ICVF) and perivascular collagen volume fraction (PCVF) were shown with picrosirius red stain (the collagen specific) and measured by image analysis system. RESULTS: THW/BW, LVD and ST of sham operation group were (0.325±s 0.016) %, (6.5±0.3)mm and (2.75±0.18)mm, respectively. In MI model group, with an IS of (26±3) %, THW/BW ((0.38±0.03) %) and LVD ((8.8±1.4)mm) were significantly increased (P<0.05, P<0.01), and ST((1.71±0.22)mm) decreased (P<0.01), compared with those in sham operation group. In captopril or lercanidipine group, IS ((18±6) %, (19±7) %) and LVD ((7.5±0.8)mm, (7.7±0.9)mm) were significantly smaller than those in MI model group(P<0.05, P<0.01), and ST ((2.4±0.4)mm, (2.4±0.5)mm) was significantly larger than that in MI model group (P<0.01). The ICVF and PCVF of the myocardium in the MI model group ((6.7±1.0) %, (67.41±0.11) %) were significantly larger than those in sham operation group ((4.0±0.5) %; (43.40±0.11) %, P<0.01 or P<0.05). In the captopril and lercanidipine groups, ICVF of myocardium was (5.0±1.0) % and (4.913±0.012) %, respectively, which was significantly smaller than that in MI model group (P<0.01). The PCVF of myocardium in the captopril and lercanidipine groups ((47.54±0.15) %, (46.18±0.18) %) were significantly decreased (P<0.01), compared with that in MI model group. CONCLUSION: Lercanidipine can improve myocardial remodeling induced by myocardial infarction in the rat.
What problem does this paper attempt to address?